Hiroshi Tazawa

10.1k total citations · 1 hit paper
332 papers, 7.8k citations indexed

About

Hiroshi Tazawa is a scholar working on Genetics, Biotechnology and Animal Science and Zoology. According to data from OpenAlex, Hiroshi Tazawa has authored 332 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Genetics, 80 papers in Biotechnology and 75 papers in Animal Science and Zoology. Recurrent topics in Hiroshi Tazawa's work include Cancer Research and Treatments (80 papers), Animal Nutrition and Physiology (74 papers) and Virus-based gene therapy research (70 papers). Hiroshi Tazawa is often cited by papers focused on Cancer Research and Treatments (80 papers), Animal Nutrition and Physiology (74 papers) and Virus-based gene therapy research (70 papers). Hiroshi Tazawa collaborates with scholars based in Japan, United States and Germany. Hiroshi Tazawa's co-authors include Toshiyoshi Fujiwara, Shunsuke Kagawa, Hitoshi Nakagama, Naoto Tsuchiya, Masashi Izumiya, Warren W. Burggren, G. C. Whittow, Shinji Kuroda, James T. Pearson and Johannes Piiper and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Hiroshi Tazawa

322 papers receiving 7.6k citations

Hit Papers

Tumor-suppressive miR-34a induces senescence-like growth ... 2007 2026 2013 2019 2007 250 500 750

Peers

Hiroshi Tazawa
Hiroshi Tazawa
Citations per year, relative to Hiroshi Tazawa Hiroshi Tazawa (= 1×) peers Karin Moelling

Countries citing papers authored by Hiroshi Tazawa

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Tazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Tazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Tazawa more than expected).

Fields of papers citing papers by Hiroshi Tazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Tazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Tazawa. The network helps show where Hiroshi Tazawa may publish in the future.

Co-authorship network of co-authors of Hiroshi Tazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Tazawa. A scholar is included among the top collaborators of Hiroshi Tazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Tazawa. Hiroshi Tazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Teruki, Kazuhiro Noma, Takuya Kato, et al.. (2024). Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody. Molecular Cancer Therapeutics. 23(7). 1031–1042. 7 indexed citations
2.
Shigeyasu, Kunitoshi, Yuzo Umeda, Shuya Yano, et al.. (2023). ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer. Scientific Reports. 13(1). 2078–2078. 11 indexed citations
3.
Saito, Hidetomo, Hiroaki Kijima, Noriyuki Ishikawa, et al.. (2022). Causes and Clinical Outcomes of Patellar Post Impingement. Arthroplasty Today. 14. 48–52. 1 indexed citations
4.
Fujiwara, Tomohiro, Mohamed A. Yakoub, Andrew Chandler, et al.. (2021). CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment. Molecular Cancer Therapeutics. 20(8). 1388–1399. 157 indexed citations
5.
Tazawa, Hiroshi, Joe Hasei, Yasuaki Yamakawa, et al.. (2021). Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression. Cancer Chemotherapy and Pharmacology. 88(3). 513–524. 13 indexed citations
6.
Kato, Takuya, Kazuhiro Noma, Toshiaki Ohara, et al.. (2018). Cancer-Associated Fibroblasts Affect Intratumoral CD8+ and FoxP3+ T Cells Via IL6 in the Tumor Microenvironment. Clinical Cancer Research. 24(19). 4820–4833. 276 indexed citations
7.
Takeda, Sho, Kunitoshi Shigeyasu, Yoshinaga Okugawa, et al.. (2018). Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer. Cancer Letters. 444. 127–135. 48 indexed citations
8.
Saito, Hidetomo, Hiroaki Kijima, Kimio Saito, et al.. (2018). The usefulness of planning using a preoperative lateral leg image to determine accurate posterior tibial slope in total knee arthroplasty. Journal of Orthopaedics. 16(1). 25–30. 4 indexed citations
9.
Kanaya, Nobuhiko, Shinji Kuroda, Tetsushi Kubota, et al.. (2017). [Novel Therapeutic Strategy for Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer].. PubMed. 44(10). 883–885. 3 indexed citations
10.
Takehara, Kiyoto, Hiroshi Tazawa, Yuuri Hashimoto, et al.. (2015). Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer. Molecular Cancer Therapeutics. 15(1). 199–208. 18 indexed citations
11.
Noma, Kazuhiro, Hajime Kashima, Takayuki Ninomiya, et al.. (2015). [Therapeutic Potential of Targeting Cancer-Associated Fibroblasts in Esophageal Cancer].. PubMed. 42(10). 1228–30. 1 indexed citations
12.
Tazawa, Hiroshi, Takeshi Nagasaka, Shunsuke Kagawa, & Toshiyoshi Fujiwara. (2015). MicroRNA as a molecular target for gastrointestinal cancers. 4(3). 219–235. 8 indexed citations
13.
Shigeyasu, Kunitoshi, Hiroshi Tazawa, Yuuri Hashimoto, et al.. (2014). Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics. Gut. 64(4). 627–635. 22 indexed citations
14.
Andrewartha, Sarah J., Hiroshi Tazawa, & Warren W. Burggren. (2014). Acute regulation of hematocrit and acid–base balance in chicken embryos in response to severe intrinsic hypercapnic hypoxia. Respiratory Physiology & Neurobiology. 195. 1–10. 15 indexed citations
15.
Hasei, Joe, Tsuyoshi Sasaki, Hiroshi Tazawa, et al.. (2013). Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells. Molecular Cancer Therapeutics. 12(3). 314–325. 53 indexed citations
16.
Yano, Shuya, Hiroshi Tazawa, Yuuri Hashimoto, et al.. (2013). A Genetically Engineered Oncolytic Adenovirus Decoys and Lethally Traps Quiescent Cancer Stem–like Cells in S/G2/M Phases. Clinical Cancer Research. 19(23). 6495–6505. 64 indexed citations
17.
Sasaki, Tsuyoshi, Hiroshi Tazawa, Joe Hasei, et al.. (2011). Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue Sarcomas. Clinical Cancer Research. 17(7). 1828–1838. 43 indexed citations
18.
Kuroda, Shinji, Toshiya Fujiwara, Yasuhiro Shirakawa, et al.. (2010). Telomerase-Dependent Oncolytic Adenovirus Sensitizes Human Cancer Cells to Ionizing Radiation via Inhibition of DNA Repair Machinery. Cancer Research. 70(22). 9339–9348. 61 indexed citations
19.
Shibasaki, Koji, et al.. (1995). Electrochemical Migration in Three Layer TAB Tape with Tin-plated Lead. 95(427). 23–29. 1 indexed citations
20.
Fukuchi, Takahiko, et al.. (1993). [Histopathology of corneal plaque in vernal keratoconjunctivitis].. PubMed. 97(2). 201–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026